{"id":2,"date":"2024-07-17T19:01:49","date_gmt":"2024-07-17T19:01:49","guid":{"rendered":"https:\/\/lab.prd.vanderbilt.edu\/mitchell-lab\/?page_id=2"},"modified":"2026-04-08T07:55:51","modified_gmt":"2026-04-08T13:55:51","slug":"index","status":"publish","type":"page","link":"https:\/\/lab.vanderbilt.edu\/mitchell-lab\/","title":{"rendered":"Home"},"content":{"rendered":"

From Genes to Molecules<\/strong><\/h4>\n

\"IllustrationWe are a chemical biology group that focuses on the study of natural products.<\/strong> Natural products are highly evolved and functionally privileged compounds that often display complex chemical structures. These molecules have inspired generations of synthetic organic chemists, unveiled numerous fundamental biological processes as chemical probes, and served as the most significant source of chemical matter for drug discovery.<\/p>\n

As the field of genomics has expanded, it has revealed a vast untapped wealth of natural products encoded in the DNA of sequenced organisms, particularly bacteria. Our lab has developed new tools to expedite the discovery of natural products from genomic information, including molecules from bacteria that cannot be cultivated in a lab. In particular, our lab focuses on Ri<\/span>bosomally synthesized and P<\/span>ost-translationally modified P<\/span>eptides (RiPPs<\/a>) which have genetically encoded substrates and an incredible diversity of post-translational modifications. Using a genes-to-molecule approach, we have uncovered numerous structurally unique RiPP molecules and revealed the unprecedented mechanistic enzymology through which they form.<\/p>\n

We can then leverage this knowledge to produce new-to-nature compounds with improved properties or novel activity with the long-term goal of unleashing the full synthetic potential of Nature to reshape the diagnosis and treatment of human disease.<\/p>\n

\n
\n
\n